drugset / Trial / NCT00112138

Gabapentin for the Treatment of Hot Flashes in Menopausal Women

NCT00112138

Phase 3 Completed 200 enrolled North Toronto Primary Care Research Network
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effectiveness and safety of gabapentin compared to placebo in the treatment of hot flashes in postmenopausal women using a phase III randomized controlled trial.

Timeline

Start
2004-03
Primary completion
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule

Indications

No indication recorded.